Docebo Inc. Form 6-K Summary
Reporting period: Three and six months ended June 30, 2022. The Form 6-K was filed in August 2022 and includes unaudited interim financial statements, management’s discussion and analysis, and the company’s second-quarter 2022 results press release.
Business Context and Reporting Period
Docebo Inc. is a Canadian foreign private issuer that files annual reports on Form 40-F. The filing covers the company’s financial position and operating results for the quarter and six-month period ended June 30, 2022.
Financial Results and Liquidity
- The provided filing text identifies the inclusion of interim financial statements but does not provide clear values for revenue, profit or loss, cash flow, margins, debt, cash balances, liquidity, or other financial metrics.
- The source text does not provide sufficient information to calculate year-over-year changes, operating margins, free cash flow, or leverage.
Material Changes Versus the Prior Comparable Period
The filing cover and exhibit list do not state the material changes in results or financial condition versus the prior comparable period. The detailed comparison would be contained in Exhibit 99.2 and the related financial statements, which are not included in the provided text.
Guidance, Outlook, Risks, and Unusual Items
- The filing text does not provide guidance, outlook commentary, risk updates, contingencies, or unusual items.
- Exhibit 99.3 is identified as a press release titled “Docebo Reports Second Quarter 2022 Results,” but its contents are not included in the source text.
Investor Verification Checklist
- Verify second-quarter and year-to-date revenue growth, recurring revenue metrics, customer and retention metrics, and geographic performance.
- Verify reported and adjusted profitability, stock-based compensation, operating expenses, and margin trends.
- Review cash flow, cash and investments, debt obligations, working capital, and liquidity.
- Review management’s guidance and outlook in Exhibits 99.2 and 99.3.
- Check for material risks, contingencies, commitments, acquisitions, or other unusual items disclosed in the detailed exhibits.